CBG

Introducing Cherry Blossom Craft CBD Flower: The Newest Addition to WholeHemp’s Sun-Grown Product Line

Retrieved on: 
Monday, May 8, 2023
Taste, High, Cannabinoid, Cherry Wine, High-intensity discharge lamp, Temperature, Carbon, CBG, Terpene, Wind, Plant, Sunlight, Pesticide, Soil, CBC, Herbicide, CBD, Cannabis, Growth, Heat, Environment, CDB, HID, Drug, Perfume

As of Thursday, May 11, 2023, you can try WholeHemp’s newest offering: outdoor-grown Cherry Blossom Craft CBD Flower.

Key Points: 
  • As of Thursday, May 11, 2023, you can try WholeHemp’s newest offering: outdoor-grown Cherry Blossom Craft CBD Flower.
  • Sun-grown outdoors in Ontario, the all-new Cherry Blossom Craft CBD Flower is a high CDB cross of Cherry Wine and Berry Blossom, creating bold berry flavours with hints of light floral notes, perfect for the summer season.
  • For instance, the Cherry Blossom Whole Flower by WholeHemp is characterized by bold berry and floral notes.
  • WholeHemp’s exclusively sun-grown Cherry Blossom Craft CBD Flower is the perfect addition to any wellness routine or a relaxing afternoon.

Smokiez Edibles Expands to New York Market

Retrieved on: 
Friday, April 21, 2023
Agriculture, Natural Resources, Tobacco, Specialty, Lifestyle, Consumer, Cannabis, Retail, Pura, Drink, USTA, Stock, Fruit, CBG, Sale, CBN, Grocery store, CBD

Smokiez Edibles, a national leader in the cannabis edibles space, is proud to announce its expansion into the New York market with licensing partner, Hepworth Ag and joint venture partner Pura Industries NY.

Key Points: 
  • Smokiez Edibles, a national leader in the cannabis edibles space, is proud to announce its expansion into the New York market with licensing partner, Hepworth Ag and joint venture partner Pura Industries NY.
  • With Smokiez high-quality and innovative products and Hepworth’s infrastructure, Smokiez Edibles is poised to become a top player in the New York cannabis industry.
  • With a focus on quality and consistency, Smokiez Edibles has become a trusted brand among cannabis consumers.
  • "We are confident that our products will resonate with New York customers," said Ryan Wright, co-owner of Smokiez Edibles.

Cronos Group Releases Cannabinoid Life Cycle Study Highlighting its Sustainable Fermentation Practices

Retrieved on: 
Friday, April 21, 2023
Corporate Affairs, Senior, Overalls, Cannabinoid, Fermentation, Carbon, CBG, Plant, Intertek, CBC, Water, CBD, Cannabis, Sustainability studies, TSX, THC, Fine chemical, Cronos

The third-party reviewed results showed that the environmental footprint of growing plants indoors is high and using innovative fermentation processes is a solution that dramatically lowers the environmental impact of cannabinoid production.

Key Points: 
  • The third-party reviewed results showed that the environmental footprint of growing plants indoors is high and using innovative fermentation processes is a solution that dramatically lowers the environmental impact of cannabinoid production.
  • On average, the carbon footprint savings of using Cronos’ fermentation method is 99.8% when compared to traditional extraction methods.1
    Cronos’ brand platform features rare cannabinoids in a wide range of product formats.
  • The Company has launched CBC and CBG-focused adult products under its Spinach FEELZ™ brand platform, both products are made using Cronos’ proprietary sustainable fermentation methods.
  • “As the cannabis industry develops, the need for a more sustainable way to produce cannabinoids, including rare cannabinoids, is vital.

MAISON BLOOM Launches All-Natural Hemp-Based THC Elevated Seltzers Establishing the All-New Craft Cannabinoid Beverage Category

Retrieved on: 
Thursday, April 20, 2023
Emerald, Single barrel whiskey, THCV, Drink, Magic, Emerald Triangle, CBG, Maison, CBN, SAN, Euphoria, Agave, THC, Tea, CBD

SAN FRANCISCO, April 20, 2023 /PRNewswire/ -- MAISON BLOOM, the leading premium craft cannabis beverage beloved and recommended by bartenders and mixologists, is proud to introduce MAISON BLOOM All-Natural Hemp-Based THC Elevated Seltzers. An evolution of the brand's signature family of Strain Specific, Whole Plant, Single Barrel craft cannabis beverages, these products deliver a carefully curated blend of botanical alchemy thanks to a unique combination of all-natural hemp-based delta-9 THC, THCV, CBD, CBG, CBN, and a proprietary blend of botanical terpenes. The brand's most expansive innovation to date was meticulously developed with Maison's signature high-quality craftsmanship and attention to detail, introducing the world to a bold new combination of plant magic and the world's first all-natural designer cannabinoid functional beverage.

Key Points: 
  • SAN FRANCISCO, April 20, 2023 /PRNewswire/ -- MAISON BLOOM , the leading premium craft cannabis beverage beloved and recommended by bartenders and mixologists, is proud to introduce MAISON BLOOM All-Natural Hemp-Based THC Elevated Seltzers .
  • "We're excited to debut MAISON BLOOM's designer novel cannabinoid family of All-Natural Hemp-Based Elevated Seltzers encompassing the whole plant, a true leap forward in what's possible in hemp-based functional food and beverages," said Chief Innovation Officer Jake Wall .
  • MAISON BLOOM has partnered with Chill State Collective to maximize Minnesota's "green rush," and additional partners across key Southern United States markets to ensure greater reach.
  • For more information on MAISON BLOOM products and to find them near you, please visit www.livemaisonbloom.com and follow @LoveMaisonBloom for new product drops and more from The Cali-Sober Cocktail Club™

Indiva Reports Record Fiscal Year 2022 Results

Retrieved on: 
Tuesday, April 18, 2023
Natural Resources, Pharmaceutical, Alternative Medicine, Health, Specialty, Food, Beverage, Cannabis, Retail, Melon, Midnight, Cream, Classification, Marketing, Sandwich, Wild cherry, TWELVE, Patient, Analysis, Ageing, Health Canada, News, Bhang, Automation, Edible, Pomegranate, Lemonade, FINANCIAL, Research, CBG, CBN, Limited, SEDAR, Growth, Consolidated, THC, Legislation, Loss, International, Financial condition report, Financial statement, Capsule, Granny Smith, CBD, Result, Bank statement, Cannabinoid, Stock, EBITDA, White chocolate, Sunset, Dime, Cryptocurrency, Pharmaceutical industry, Video game, Dietary supplement, Tea, Candy, Security (finance), Medical device, Oil, Indiva, Vanilla, Pearl, Tilray

Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022.

Key Points: 
  • Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022.
  • “We are pleased to report record revenue and record gross profit for the fiscal year 2022.
  • In 2022, Indiva introduced several new products from in-house innovation under the Indiva Life brand including Lozenges, Chocolates, Capsules and Sandwich Cookies.
  • Indiva also led the baked goods category with 49.6% sub-category share which includes recently launched Indiva Life Double-Stuffed Cookies.

The Hemp Doctor Launches Kayo Rapid Release Gummies, a Revolutionary Nano-Emulsified Gummy

Retrieved on: 
Friday, April 14, 2023
Cannabis, Granny Smith, CBN, THCV, Cannabinoid, Nano, CBC, CBG, Delta

"We are thrilled to introduce Kayo Rapid Release Gummies to our customers," said Robert Shade, Founder of The Hemp Doctor.

Key Points: 
  • "We are thrilled to introduce Kayo Rapid Release Gummies to our customers," said Robert Shade, Founder of The Hemp Doctor.
  • We believe that Kayo Rapid Release Gummies are a game-changer in the hemp industry, offering a new and highly effective way to experience the benefits of hemp."
  • All of The Hemp Doctor's products, including Kayo Rapid Release Gummies, are made using premium hemp and are third-party lab tested for purity and potency.
  • Kayo Rapid Release Gummies are now available for purchase on The Hemp Doctor's website, and orders are shipped nationwide.

Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU

Retrieved on: 
Friday, April 14, 2023
Chewels, US Foods, Neuropharmacology, Dermatitis, Atopic dermatitis, Doctor of Philosophy, Nicotine gum, Incidence, Acquisition, Patient, DMPK, API, Opioid overdose, Disease, Maintenance, Substance dependence, Nicotine, Research, USD, CBG, CDC, CGMP, Addiction, Smoking, Cannabidiol, Skin, Safety, British Columbia Centre for Disease Control, Opioid use disorder, Psoriasis, Translational medicine, European, Immune system, Vitiligo, LC-MS/MS, Opioid, Fatal, ASX, QPS, Food, Pharmaceutical industry, MD, Toxicology, CBD, Cannabigerol, Eurofins Scientific

Over the years, QPS has adopted additional services, including Neuropharmacology, DMPK, Toxicology, Translational Medicine, Early Phase Clinical Research and Phase II – IV Clinical Research.

Key Points: 
  • Over the years, QPS has adopted additional services, including Neuropharmacology, DMPK, Toxicology, Translational Medicine, Early Phase Clinical Research and Phase II – IV Clinical Research.
  • QPS is currently drafting pre-investigational new drug (pre-IND) submissions for both the European Union’s European Medicines Agency (‘EMA’) and the US Food and Drug Administration (‘FDA’) for the CannQuit™ and ReneCann™ Products.
  • CEO and Managing Director, Mr Joel Latham said; “QPS is a perfect fit for us to develop these products across the globe.
  • Data collected by Eurofins on the quality and stability of the products will be key components of future regulatory packages.

Wyld Introduces New Blood Orange THC:CBC 1:1 Sativa-Enhanced Gummies

Retrieved on: 
Wednesday, April 5, 2023
Climate, Good Tidings and Great Joy, Brain, Cannabinoid, CBG, CBN, Pomegranate, CBC, Happiness, CBD, Cannabis, THC, Dietary supplement, Wyld

CLACKAMAS, Ore., April 5, 2023 /PRNewswire/ -- Wyld, one of the top five cannabis brands in the U.S., known for their best-selling cannabis infused edibles, is expanding their product line with a Sativa-enhanced blood orange gummy containing both THC and CBC.

Key Points: 
  • The introduction of the blood orange gummy into Wyld's line up brings the total number of flavors to 11: elderberry, huckleberry, marionberry, raspberry, pomegranate, peach, pear, strawberry, sour cherry, sour apple, and now, blood orange.
  • The blood orange gummy is Wyld's first to be made with cannabichromene, more commonly called CBC.
  • "CBC gummies, like our CBG, CBN, and CBD ratio gummies, are a perfect addition to our product line up.
  • Blood Orange THC:CBC 1:1 Sativa-enhanced gummies will be available in the US and Canada this Spring.

WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT

Retrieved on: 
Tuesday, March 28, 2023
Precigen, Xavier University, LLP, Lead, Codexis, University, Genetic engineering, Willow Springs Distilling Company, Army Science Board, PwC, Barr Pharmaceuticals, AGM, Certified Public Accountant, CBG, Development, Amyris, Partner, Chris, TSX, Growth, CFO, Research, WLLW, Compensated emancipation, Management, Willow

Since joining Willow, Dr. Savile has led the development of the technology platform, building of the operational capabilities, and expansion of the internal portfolio and external partnerships.

Key Points: 
  • Since joining Willow, Dr. Savile has led the development of the technology platform, building of the operational capabilities, and expansion of the internal portfolio and external partnerships.
  • Prior to joining Willow, Dr. Savile worked in senior leadership roles at Intrexon Corporation, a biotechnology company, and Codexis, Inc., a protein engineering company.
  • "Chris' extensive scientific knowledge and business development experience will be invaluable to Willow in its next phase of growth," said Trevor Peters, Chairman of the Board.
  • "Willow is grateful to Dr. Seufer-Wasserthal's vision and talent," said Trevor Peters, Chairman of the Board of the Company.

WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLECULES IN A NATURAL WAY

Retrieved on: 
Wednesday, March 22, 2023
Active ingredient, Pharma, Health, AB, Fermentation, CBG, WILLOW, CDMO, TSX, API, WLLW, Industrial, M3, Technology transfer, Food, Wellness, Fine chemical, Cannabigerol

The 36 m3 scaling-up production batches required for the forthcoming qualification and registration will be completed during 2023.

Key Points: 
  • The 36 m3 scaling-up production batches required for the forthcoming qualification and registration will be completed during 2023.
  • SUANFARMA' s CIPAN manufacturing site has significant expertise as a CDMO in fermentation and purification technologies under the highest standards of quality.
  • WILLOW BIOSCIENCES is a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients using its FutureGrown™ platform.
  • "CIPAN has proven itself a highly capable manufacturing partner with the efficient scaling and production of our first ingredient, CBG.